IL95890A0 - Hiv related peptides - Google Patents

Hiv related peptides

Info

Publication number
IL95890A0
IL95890A0 IL95890A IL9589090A IL95890A0 IL 95890 A0 IL95890 A0 IL 95890A0 IL 95890 A IL95890 A IL 95890A IL 9589090 A IL9589090 A IL 9589090A IL 95890 A0 IL95890 A0 IL 95890A0
Authority
IL
Israel
Prior art keywords
hiv
terminal
related peptides
hiv related
peptides
Prior art date
Application number
IL95890A
Other languages
English (en)
Original Assignee
Univ George Washington
Viral Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL95890(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ George Washington, Viral Technologies Inc filed Critical Univ George Washington
Publication of IL95890A0 publication Critical patent/IL95890A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL95890A 1989-10-12 1990-10-03 Hiv related peptides IL95890A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
IL95890A0 true IL95890A0 (en) 1991-07-18

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95890A IL95890A0 (en) 1989-10-12 1990-10-03 Hiv related peptides

Country Status (17)

Country Link
EP (3) EP0620010A1 (de)
JP (1) JPH03209398A (de)
KR (1) KR910007962A (de)
CN (1) CN1052310A (de)
AT (1) ATE119166T1 (de)
AU (1) AU6393990A (de)
CA (1) CA2027455A1 (de)
DE (1) DE69017352T2 (de)
DK (1) DK0426314T3 (de)
ES (1) ES2071038T3 (de)
GB (1) GB2236754A (de)
GR (1) GR3015244T3 (de)
HU (1) HUT55035A (de)
IE (1) IE67533B1 (de)
IL (1) IL95890A0 (de)
NZ (1) NZ235538A (de)
ZA (1) ZA907944B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6103239A (en) 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
DE60237373D1 (de) 2001-08-07 2010-09-30 Medestea Internaz S R L Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164696A (ja) * 1986-01-06 1987-07-21 エフ．ホフマン　―　ラ　ロシュ　アーゲー ＨＴＬＶ−３ｇａｇ遺伝子の発現
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion

Also Published As

Publication number Publication date
NZ235538A (en) 1992-06-25
GR3015244T3 (en) 1995-06-30
GB2236754A (en) 1991-04-17
IE67533B1 (en) 1996-04-03
KR910007962A (ko) 1991-05-30
GB9021942D0 (en) 1990-11-21
ZA907944B (en) 1991-10-30
EP0620010A1 (de) 1994-10-19
ATE119166T1 (de) 1995-03-15
EP0426314A3 (en) 1991-07-24
AU6393990A (en) 1991-04-18
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
ES2071038T3 (es) 1995-06-16
DK0426314T3 (da) 1995-03-27
CA2027455A1 (en) 1991-04-13
EP0426314A2 (de) 1991-05-08
CN1052310A (zh) 1991-06-19
DE69017352T2 (de) 1995-10-05
EP0620009A1 (de) 1994-10-19
IE903604A1 (en) 1991-04-24
DE69017352D1 (de) 1995-04-06
EP0426314B1 (de) 1995-03-01
JPH03209398A (ja) 1991-09-12

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
AU1353295A (en) Peptides derived from a retrovirus of the HIV group, and their use
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
WO1991009872A3 (en) Hiv-1 env fragment fusion protein
IL95742A (en) Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
US4755380A (en) Peptide from amyloid A and antiserum therefor
EP0426314A3 (en) Hiv related peptides
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
EP0177814A3 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
GB2299994B (en) Equine arteritis virus peptides; antibodies and their use in a diagnostic test
PT87239A (pt) Process for the preparation of peptides
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez